Login / Signup

A Short Review on Miniaturized Biosensors for the Detection of Nucleic Acid Biomarkers.

Madhusudan B KulkarniNarasimha H AyachitTejraj M Aminabhavi
Published in: Biosensors (2023)
Even today, most biomarker testing is executed in centralized, dedicated laboratories using bulky instruments, automated analyzers, and increased analysis time and expenses. The development of miniaturized, faster, low-cost microdevices is immensely anticipated for substituting for these conventional laboratory-oriented assays and transferring diagnostic results directly onto the patient's smartphone using a cloud server. Pioneering biosensor-based approaches might make it possible to test biomarkers with reliability in a decentralized setting, but there are still a number of issues and restrictions that must be resolved before the development and use of several biosensors for the proper understanding of the measured biomarkers of numerous bioanalytes such as DNA, RNA, urine, and blood. One of the most promising processes to address some of the issues relating to the growing demand for susceptible, quick, and affordable analysis techniques in medical diagnostics is the creation of biosensors. This article critically discusses a short review of biosensors used for detecting nucleic acid biomarkers, and their use in biomedical prognostics will be addressed while considering several essential characteristics.
Keyphrases
  • nucleic acid
  • label free
  • low cost
  • healthcare
  • high throughput
  • case report
  • gold nanoparticles
  • circulating tumor
  • single molecule
  • quantum dots